ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
about
LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.Methyltransferase G9a promotes cervical cancer angiogenesis and decreases patient survival.NGS-based methylation profiling differentiates TCF3-HLF and TCF3-PBX1 positive B-cell acute lymphoblastic leukemia.
P2860
ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ERα propelled aberrant global ...... in human breast cancer cells.
@en
ERα propelled aberrant global ...... in human breast cancer cells.
@nl
type
label
ERα propelled aberrant global ...... in human breast cancer cells.
@en
ERα propelled aberrant global ...... in human breast cancer cells.
@nl
prefLabel
ERα propelled aberrant global ...... in human breast cancer cells.
@en
ERα propelled aberrant global ...... in human breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
ERα propelled aberrant global ...... in human breast cancer cells.
@en
P2093
Dongliang Zhu
Haijian Ding
Jinghuan Lv
Lipei Shao
Xin A Zhang
P2860
P304
20966-20980
P356
10.18632/ONCOTARGET.8038
P407
P577
2016-03-12T00:00:00Z